Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
The originally published version of this Article contained an error in Figure 6. In panel b, the top graph (BrdU 21–24d) and the bottom graph (BrdU 28–31d) were inadvertently swapped. This error has now been corrected in both the PDF and HTML versions of the Article.
Saved in:
Main Authors: | James S. Novak, Marshall W. Hogarth, Jessica F. Boehler, Marie Nearing, Maria C. Vila, Raul Heredia, Alyson A. Fiorillo, Aiping Zhang, Yetrib Hathout, Eric P. Hoffman, Jyoti K. Jaiswal, Kanneboyina Nagaraju, Sebahattin Cirak, Terence A. Partridge |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/a9e3c5af6e8f42de973b74b8f858aefb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
by: James S. Novak, et al.
Published: (2017) -
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
by: James S. Novak, et al.
Published: (2018) -
Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice
by: Wang M, et al.
Published: (2015) -
Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers
by: Chengxi Li, et al.
Published: (2021) -
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
by: Niels Grote Beverborg, et al.
Published: (2021)